Mihailovic et al., 2017 - Google Patents
The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE (-/-) miceMihailovic et al., 2017
View HTML- Document ID
- 4865788926612028027
- Author
- Mihailovic P
- Lio W
- Yano J
- Zhao X
- Zhou J
- Chyu K
- Shah P
- Cercek B
- Dimayuga P
- Publication year
- Publication venue
- PloS one
External Links
Snippet
Auto-immunity is believed to contribute to inflammation in atherosclerosis. The antimicrobial peptide LL-37, a fragment of the cathelicidin protein precursor hCAP18, was previously identified as an autoantigen in psoriasis. Given the reported link between psoriasis and …
- 206010003210 Arteriosclerosis 0 title abstract description 57
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mihailovic et al. | The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE (-/-) mice | |
Dehner et al. | The microbiome in systemic autoimmune disease: mechanistic insights from recent studies | |
De Groot et al. | Immunogenicity of protein therapeutics | |
Gisterå et al. | Low-density lipoprotein-reactive T cells regulate plasma cholesterol levels and development of atherosclerosis in humanized hypercholesterolemic mice | |
Übelhart et al. | Responsiveness of B cells is regulated by the hinge region of IgD | |
Tse et al. | T cells in atherosclerosis | |
Tse et al. | Atheroprotective vaccination with MHC-II restricted peptides from ApoB-100 | |
Todd et al. | The endoplasmic reticulum stress response in immunity and autoimmunity | |
Mandal et al. | Autoimmunity to heat shock proteins in atherosclerosis | |
Smith et al. | Unraveling the effect of immunogenicity on the PK/PD, efficacy, and safety of therapeutic proteins | |
Falta et al. | Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease | |
Abdulla et al. | Proteomic identification of IPSE/alpha-1 as a major hepatotoxin secreted by Schistosoma mansoni eggs | |
Mahesh et al. | Alpha tropomyosin as a self-antigen in patients with Behcet's disease | |
Kuraoka et al. | Recall of B cell memory depends on relative locations of prime and boost immunization | |
Wang et al. | Significance of glycosylphosphatidylinositol-anchored protein enrichment in lipid rafts for the control of autoimmunity | |
Sakamoto et al. | Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans | |
Shaw et al. | T-cells specific for a self-peptide of ApoB-100 exacerbate aortic atheroma in murine atherosclerosis | |
Shimoda et al. | The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis | |
Boettcher et al. | Porcine signal regulatory protein alpha binds to human CD47 to inhibit phagocytosis: Implications for human hematopoietic stem cell transplantation into severe combined immunodeficient pigs | |
Chang et al. | Innate immunity drives the initiation of a murine model of primary biliary cirrhosis | |
Mantani et al. | Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice | |
Huang et al. | Improved transgenic mouse model for studying HLA class I antigen presentation | |
Zhao et al. | Cartilage oligomeric matrix protein induced arthritis—a new model for rheumatoid arthritis in the C57BL/6 mouse | |
Igel et al. | Distinct pro-inflammatory properties of myeloid cell–derived apolipoprotein E2 and E4 in atherosclerosis promotion | |
Foteinos et al. | Immune-mediated mechanisms of endothelial damage in atherosclerosis |